NEWS

News Articles

FDA authorizes first Covid-19 booster shot for teens aged 12 to 15

January 6, 2022

The Food and Drug Administration on Monday extended the emergency use authorization for the Pfizer and BioNTech Covid-19 booster shot to include teens aged 12 to 15, paving the way for them to be eligible for the jabs later this week. It is the first booster shot to be authorized for this age group. A…

Read More

U.S. Logs Record 1 Million Virus Cases With Data Delay

January 6, 2022

Uneven reporting around holiday season contributes to surge Officials hopeful that deaths won’t rise as much as infections The U.S. added more than 1 million people to its Covid-19 case count on Monday as the true scope of a surge in infections over the holidays began to round into view. The highly mutated variant, combined…

Read More

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

December 23, 2021

•    PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) is authorized for emergency use in both high-risk adults and high-risk pediatric patients 12 years of age and older weighing at least 40 kg•    EUA based on clinical data from EPIC-HR study, showing PAXLOVID reduced risk of hospitalization or death by 89% (within three days of symptom…

Read More

THE CENTER FOR GLOBAL HEALTH INNOVATION LAUNCHES INNOVATION DISTRICT IN 47-STORY TOWER IN MIDTOWN ATLANTA

December 22, 2021

District’s launch enabled by strategic partnerships across philanthropic and industry leaders, includingSharecare, Transwestern and anonymous West Coast foundation ATLANTA – The Center for Global Health Innovation (CGHI) today announced the launch of a new global health district in Midtown Atlanta that is poised to become the world’s leading hub for innovation at the intersection of…

Read More

Avanos Medical agrees to acquire OrthogenRx for $160m

December 16, 2021

The acquisition of OrthogenRx’s products will complement Avanos’ COOLIEF cooled RF treatment portfolio. Avanos Medical has signed a definitive agreement to acquire medical device firm OrthogenRx in a deal valued at about $160m. OrthogenRx is focused on developing and commercialising therapies to treat knee pain that is caused by osteoarthritis (OA). Its current product portfolio…

Read More

Japanese Scientists Claim Vaccine Removes ‘Zombie’ Cells Behind ‘Aging-Related Diseases’

December 16, 2021

Scientists in Japan have unveiled a new vaccine that they claim can eliminate so-called “zombie cells” associated with aging and various diseases. The research team behind the vaccine, led by professor Toru Minamino of Juntendo University, published the results of their study on Friday in the Nature Aging journal. According to these results, mice given the vaccine…

Read More